BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 118 filers reported holding BIOSCRIP INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $7,082,000 | +30.0% | 2,723,753 | 0.0% | 4.61% | +26.2% |
| Q1 2019 | $5,448,000 | -9.0% | 2,723,753 | +62.3% | 3.66% | +5.3% |
| Q4 2018 | $5,990,000 | -6.2% | 1,677,753 | -18.5% | 3.47% | -5.8% |
| Q3 2018 | $6,384,000 | -52.5% | 2,059,264 | -55.1% | 3.68% | -6.8% |
| Q2 2018 | $13,438,000 | +128.3% | 4,586,328 | +91.6% | 3.95% | +27.6% |
| Q1 2018 | $5,887,000 | -32.4% | 2,393,164 | -20.0% | 3.10% | -41.7% |
| Q4 2017 | $8,710,000 | -65.2% | 2,993,164 | -67.1% | 5.32% | -2.0% |
| Q3 2017 | $25,041,000 | +203.9% | 9,105,492 | +200.0% | 5.42% | -23.2% |
| Q2 2017 | $8,240,000 | +118.6% | 3,035,164 | +36.9% | 7.06% | +73.5% |
| Q1 2017 | $3,769,000 | +55.5% | 2,217,164 | -4.9% | 4.07% | +240.3% |
| Q4 2016 | $2,424,000 | -62.7% | 2,330,774 | +3.6% | 1.20% | -85.0% |
| Q3 2016 | $6,503,000 | +13.3% | 2,250,000 | 0.0% | 7.99% | +10.5% |
| Q2 2016 | $5,738,000 | – | 2,250,000 | – | 7.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venor Capital Management LP | 12,005,453 | $20,409,000 | 10.92% |
| Coliseum Capital Management, LLC | 5,622,410 | $9,558,000 | 4.30% |
| Alta Fundamental Advisers LLC | 2,217,164 | $3,769,000 | 4.07% |
| WYNNEFIELD CAPITAL INC | 3,800,000 | $6,460,000 | 2.37% |
| ARDSLEY ADVISORY PARTNERS LP | 5,280,000 | $8,976,000 | 1.40% |
| NORTH TIDE CAPITAL, LLC | 3,000,000 | $5,100,000 | 0.78% |
| Camber Capital Management LP | 10,180,000 | $17,306,000 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 310,500 | $528,000 | 0.54% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 233,280 | $397,000 | 0.19% |
| Eidelman Virant Capital | 140,000 | $238,000 | 0.16% |